Topical Placebo Gel

DRUG2 trials

Sponsors

Ain Shams University, BioMendics, LLC

Conditions

Epidermolysis Bullosa SimplexOral Potentially Malignant Lesions

Phase 1

Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions

CompletedNCT06271564

Ain Shams UniversityOral Potentially Malignant Lesions

Start: 2024-02-29End: 2026-04-02Updated: 2026-04-07

Phase 2

A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

RecruitingNCT07027345

BioMendics, LLCEpidermolysis Bullosa Simplex

Start: 2025-09-11End: 2027-09-01Target: 40Updated: 2026-08-13